156 related articles for article (PubMed ID: 27914680)
1. Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT.
Wijsman R; Dankers F; Troost EGC; Hoffmann AL; van der Heijden EHFM; de Geus-Oei LF; Bussink J
Radiother Oncol; 2017 Feb; 122(2):295-299. PubMed ID: 27914680
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiotherapy and volumetric-modulated arc therapy have distinct clinical advantages in non-small cell lung cancer treatment.
Zhang J; Yu XL; Zheng GF; Zhao F
Med Oncol; 2015 Apr; 32(4):94. PubMed ID: 25725813
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Flattening Filter Free on Three-dimensional Conformal Radiation Therapy (3D-CRT), Intensity-Modulated Radiation Therapy (IMRT), and Volumetric Modulated Arc Therapy (VMAT) Plans for Metastatic Brain Tumors from Non-small Cell Lung Cancer.
Shi LW; Lai YQ; Lin Q; Ha HM; Fu LR
Health Phys; 2015 Jul; 109(1):1-9. PubMed ID: 26011493
[TBL] [Abstract][Full Text] [Related]
4. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.
Wang D; Bi N; Zhang T; Zhou Z; Xiao Z; Liang J; Chen D; Hui Z; Lv J; Wang X; Wang X; Deng L; Wang W; Wang J; Wang C; Lu X; Xu K; Wu L; Xue W; Feng Q; Wang L
Radiat Oncol; 2019 Jun; 14(1):106. PubMed ID: 31196118
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
Ling DC; Hess CB; Chen AM; Daly ME
Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in Chinese population: A retrospective study.
Xu Y; Zheng X; Bai X; Li P; Ma H; Wang J; Hu X; Chen M
Oncotarget; 2017 Jul; 8(30):49084-49092. PubMed ID: 28467775
[TBL] [Abstract][Full Text] [Related]
8. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
[TBL] [Abstract][Full Text] [Related]
9. Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy.
Wijsman R; Dankers F; Troost EG; Hoffmann AL; van der Heijden EH; de Geus-Oei LF; Bussink J
Radiother Oncol; 2015 Oct; 117(1):49-54. PubMed ID: 26341608
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.
Jiang ZQ; Yang K; Komaki R; Wei X; Tucker SL; Zhuang Y; Martel MK; Vedam S; Balter P; Zhu G; Gomez D; Lu C; Mohan R; Cox JD; Liao Z
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):332-9. PubMed ID: 22079735
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of Radiation Techniques in Patients Treated With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer.
Peng J; Pond G; Donovan E; Ellis PM; Swaminath A
Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):985-992. PubMed ID: 32007366
[TBL] [Abstract][Full Text] [Related]
12. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of a novel hybrid intensity-modulated radiotherapy technique for stage III lung cancer and dosimetric comparison with four other techniques.
Verbakel WF; van Reij E; Ladenius-Lischer I; Cuijpers JP; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e297-303. PubMed ID: 22579380
[TBL] [Abstract][Full Text] [Related]
14. Intrafraction Motion in Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: Intensity Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy.
Rossi MM; Peulen HM; Belderbos JS; Sonke JJ
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):835-43. PubMed ID: 27131084
[TBL] [Abstract][Full Text] [Related]
15. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive dosimetric planning comparison for early-stage, non-small cell lung cancer with SABR: fixed-beam IMRT versus VMAT versus TomoTherapy.
Xhaferllari I; El-Sherif O; Gaede S
J Appl Clin Med Phys; 2016 Sep; 17(5):329-340. PubMed ID: 27685129
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
[TBL] [Abstract][Full Text] [Related]
18. Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.
Jegadeesh N; Liu Y; Gillespie T; Fernandez F; Ramalingam S; Mikell J; Lipscomb J; Curran WJ; Higgins KA
Clin Lung Cancer; 2016 Sep; 17(5):398-405. PubMed ID: 26936682
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer.
Pollom EL; Qian Y; Durkee BY; von Eyben R; Maxim PG; Shultz DB; Gensheimer M; Diehn M; Loo BW
Clin Lung Cancer; 2016 Nov; 17(6):588-594. PubMed ID: 27378172
[TBL] [Abstract][Full Text] [Related]
20. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.
Liao ZX; Komaki RR; Thames HD; Liu HH; Tucker SL; Mohan R; Martel MK; Wei X; Yang K; Kim ES; Blumenschein G; Hong WK; Cox JD
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):775-81. PubMed ID: 19515503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
